Complexities in the treatment of coinfection with HIV, hepatitis B, hepatitis C, and tuberculosis

This article describes the challenges faced in formulating a therapeutic plan for such patients and discusses the various drug interactions that can arise between antitubercular drugs, antiretrovirals, anti-HBV drugs, and direct-acting antivirals against HCV.

Source:

The Lancet Infectious Diseases